These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 17664322

  • 21. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [Abstract] [Full Text] [Related]

  • 22. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF.
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [Abstract] [Full Text] [Related]

  • 23. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N, Akduman D, Aydemir H, Celebi G, Oztoprak N, Aktaş E.
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [Abstract] [Full Text] [Related]

  • 24. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 25. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.
    Ruotsalainen E, Sammalkorpi K, Laine J, Huotari K, Sarna S, Valtonen V, Järvinen A.
    BMC Infect Dis; 2006 Sep 11; 6():137. PubMed ID: 16965625
    [Abstract] [Full Text] [Related]

  • 26. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
    Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250
    [Abstract] [Full Text] [Related]

  • 27. Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis.
    Stroup JS, Wagner J, Badzinski T.
    Ann Pharmacother; 2010 Apr 15; 44(4):746-9. PubMed ID: 20197474
    [Abstract] [Full Text] [Related]

  • 28. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR.
    Clin Infect Dis; 2009 May 15; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [Abstract] [Full Text] [Related]

  • 29. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW.
    Clin Infect Dis; 2003 Sep 15; 37(6):794-9. PubMed ID: 12955640
    [Abstract] [Full Text] [Related]

  • 30. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 31. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
    Kuo CB, Lin JC, Peng MY, Wang NC, Chang FY.
    J Microbiol Immunol Infect; 2007 Aug 01; 40(4):317-24. PubMed ID: 17712466
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T, Vicente MV, Rodríguez A.
    J Chemother; 1989 Jul 01; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract] [Full Text] [Related]

  • 33. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
    Pericàs JM, Messina JA, Garcia-de-la-Mària C, Park L, Sharma-Kuinkel BK, Marco F, Wray D, Kanafani ZA, Carugati M, Durante-Mangoni E, Tattevin P, Chu VH, Moreno A, Fowler VG, Miró JM, International Collaboration on Endocarditis Microbiology Investigators.
    Clin Microbiol Infect; 2017 Aug 01; 23(8):544-549. PubMed ID: 28159672
    [Abstract] [Full Text] [Related]

  • 34. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.
    Clin Infect Dis; 2008 Mar 15; 46(6):799-806. PubMed ID: 18266610
    [Abstract] [Full Text] [Related]

  • 35. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
    Campelli A, Mantero E, Fabbri A, Nahum M, Ferraris R, Di Noto C.
    Minerva Med; 1984 Feb 28; 75(8):385-90. PubMed ID: 6709217
    [Abstract] [Full Text] [Related]

  • 36. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK, Yeaman MR, Bayer AS.
    J Infect Dis; 1999 Nov 28; 180(5):1561-8. PubMed ID: 10515816
    [Abstract] [Full Text] [Related]

  • 37. Methicillin-resistant Staphylococcus aureus sclerokeratitis after pterygium excision.
    Lee JE, Oum BS, Choi HY, Lee JS.
    Cornea; 2007 Jul 28; 26(6):744-6. PubMed ID: 17592329
    [Abstract] [Full Text] [Related]

  • 38. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
    Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, White AC.
    J Infect; 2007 Jun 28; 54(6):539-44. PubMed ID: 17198732
    [Abstract] [Full Text] [Related]

  • 39. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S, Saner FH, Rath PM, Kaiser GM, Mathe Z, Treckmann J, Paul A.
    Transpl Infect Dis; 2009 Aug 28; 11(4):346-8. PubMed ID: 19497075
    [Abstract] [Full Text] [Related]

  • 40. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.
    Clin Infect Dis; 2009 Sep 01; 49(5):691-8. PubMed ID: 19635023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.